Gosain, S., Bullement, A. orcid.org/0000-0001-7091-0972, Kirby, J. et al. (3 more authors) (2018) Comparison of pharmacoeconomic (PE) evaluations for drugs for rare diseases (DRDs) evaluated by CADTH and NICE. In: Value in Health. ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S465.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018 Published by Elsevier Inc. This is an author produced version of an abstract subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 22 Jan 2021 11:21 |
Last Modified: | 22 Jan 2021 11:21 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.jval.2018.09.2741 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:169359 |
Download
Filename: ISPOR poster abstract (CADTH vs NICE).pdf
Licence: CC-BY-NC-ND 4.0